SS

Sulochana Saroj Sahu

Active Director Director DIN 11704230
DIN 11704230 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sulochana Saroj Sahu

Data last updated:

Sulochana Saroj Sahu is a Director at Kuros Healthcare Private Limited (since 2026) and Director at Bionexis Pharmaceuticals Private Limited (since 2026).

DIN 11704230
Primary Designation Director
First Appointment 07 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kuros Healthcare Private Limited U86905MH2026PTC473085
Director04 Jul 20262026Active
Director07 May 20262026Active

Directorship timeline

Open interactive timeline →
Bionexis Pharmaceuticals Private Limited
Kuros Healthcare Private Limited
Premium access

Shareholding and investment profile for Sulochana Saroj Sahu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sulochana Saroj Sahu

Sulochana Saroj Sahu currently holds 2 directorships: Kuros Healthcare Private Limited (Director, since 04 Jul 2026); Bionexis Pharmaceuticals Private Limited (Director, since 07 May 2026).

Sulochana Saroj Sahu was first appointed on 07 May 2026 as Director at Bionexis Pharmaceuticals Private Limited.

The current boards of Sulochana Saroj Sahu's companies include Alok Saroj Sahu (Kuros Healthcare Private Limited), Siddhant Satyaprakash Shetty (Kuros Healthcare Private Limited), Aditya Saroj Sahu (Bionexis Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available